Clinical Trials Logo

Clinical Trial Summary

In this project, we will examine individual differences in the effects of a stimulant drug, methamphetamine (MA), on mesolimbic reward function using fMRI.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04642820
Study type Interventional
Source University of Chicago
Contact Matthew Bona
Phone 773-702-3560
Email dewitlab@yoda.bsd.uchicago.edu
Status Recruiting
Phase Early Phase 1
Start date November 1, 2020
Completion date June 1, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT04061941 - Change in Cognitive Function in Stimulant Users
Not yet recruiting NCT05097547 - Contingency Management for Stimulant Use Disorders N/A
Recruiting NCT06073340 - The Longitudinal Study of Stimulant Use Disorder
Completed NCT05379959 - Effects of Stimulants on Behavioral and Neural Markers of Social Motivation, Ability, and Neural Markers of Social Function Early Phase 1
Recruiting NCT05835921 - Enhancing Prospective Thinking in Early Recovery N/A
Recruiting NCT05140876 - Supporting Treatment Adherence for Resilience and Thriving (START) N/A
Withdrawn NCT04553263 - Relapse Prevention in Stimulant Use Disorder Early Phase 1
Recruiting NCT04426214 - Neuromodulation and Cognitive Training for Substance Use Disorders N/A
Recruiting NCT04899024 - PrEP Affect Regulation Treatment Innovation N/A
Recruiting NCT03470480 - rTMS for Craving in Methamphetamine Use Disorder N/A
Active, not recruiting NCT04907357 - rTMS for Stimulant Use Disorders N/A
Not yet recruiting NCT05787847 - Financial Incentives to Promote Stimulant Abstinence in a Community-Based Syringe Exchange Program N/A
Recruiting NCT03935646 - Acute Effects of Stimulant Medication in College Students With ADHD Phase 2